SEAL THERAPEUTICS

Congenital muscular dystrophy is a rare hereditary disease which leads to muscle weakness and loss already at young age. The more than thirty known forms of this neuromuscular disease differ in the type of genetic defect and in the severity of disease progression. SEAL Therapeutics focuses on LAMA2-related muscular dystrophy (LAMA2 MD), a severe form of muscular dystrophy caused by the absence of laminin-alpha 2 in the muscle fibers. There is currently no specific treatment for patients with LAMA2 MD.

Also known as: SEAL Therapeutics AG

Primary location: Basel Switzerland